Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eleven Biotherapeutics Inc (NASDAQ:EBIO)

2.08
Delayed Data
As of Feb 17
 +0.04 / +1.96%
Today’s Change
0.27
Today|||52-Week Range
5.97
+8.90%
Year-to-Date
No recent news for Eleven Biotherapeutics Inc.

Today’s Trading

Previous close2.04
Today’s open2.04
Day’s range2.02 - 2.12
Volume268,704
Average volume (3 months)997,700
Market cap$50.4M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)+25.74%
Earnings growth (this year)+0.57%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)-55.86%
P/E ratioNM
Price/Sales57.75
Price/Book2.15

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...-0.01-0.24%
AMPEAmpio Pharmaceutical...-0.01-1.55%
JNPJuniper Pharmaceutic...-0.10-2.04%
MTEXMannatech Inc+0.65+3.45%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$990.0K
Annual profit (last year)-$33.5M
Net profit margin-3,378.99%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen Allen Hurly
CFO &
Principal Accounting Officer
John J. McCabe
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs